COVID-19 vaccine booster induces a strong CD8 <sup>+</sup> T cell response against Omicron variant epitopes in HLA-A*02:01 <sup>+</sup> individuals
Andrea Nguyen(Monash Health), Stéphanie Gras(La Trobe University), Corey Smith(QIMR Berghofer Medical Research Institute), Christopher Szeto(La Trobe University), You Min Ahn(La Trobe University), Dhilshan Jayasinghe(La Trobe University), Michael J. Dewar-Oldis(La Trobe University), Bradley J. Gardiner(Monash Alfred Psychiatry Research centre), Lucy Cooper(Discovery Institute), Kirsty R. Short(The University of Queensland), Emma J. Grant(La Trobe University), Zhen Tong(The University of Queensland), Katie E. Lineburg(QIMR Berghofer Medical Research Institute), Peter J. Barnard(La Trobe University), Demetra S.M. Chatzileontiadou(La Trobe University), Alan Riboldi-Tunicliffe(Australian Nuclear Science and Technology Organisation), Christian A. Lobos(La Trobe University), Kim L. Good‐Jacobson(Discovery Institute), James McMahon, Lawton D. Murdolo(La Trobe University), Keng Yih Chew(Australian Research Council), Rachel Williamson(Australian Nuclear Science and Technology Organisation)
Cited by 4
Related Papers
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition
|Nature Medicine|2018|282
Back to the Future: Lessons Learned From the 1918 Influenza Pandemic
|Frontiers in Cellular and Infection Microbiology|2018|282
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
|Cancer Discovery|2019|272
Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients.
|Journal of Clinical Pathology|1984|261